TabletErlotinib 150mg
Erlotinib Hydrochloride
First-generation EGFR tyrosine kinase inhibitor that competitively blocks ATP binding to EGFR, suppressing downstream RAS-MAPK and PI3K-AKT tumour survival signalling in EGFR-mutant NSCLC. It is also approved at 100mg in combination with gemcitabine for locally advanced or metastatic pancreatic cancer, where it provides a modest but statistically significant survival benefit. Cipla and Glenmark supply export-quality generics in 100mg and 150mg tablets as affordable alternatives to Tarceva.
Strengths
100mg / 150mg
Packing
30 tablets/bottle
Origin
India (WHO-GMP)
MOQ
100 units
Export Price
On Request
Availability
In Stock
Product Specifications
Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.
Related Products
TabletSorafenib 200mg
Sorafenib Tosylate
Soranib (Sorafenib 200mg) is an oral anti-cancer medicine that works by blocking abnormal protein signals that cause cancer cells to multiply. It helps stop or slow the spread of cancer in hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma. Available for global pharmaceutical export with WHO-GMP certification.
CapsuleLenalidomide 25mg
Lenalidomide
Lenalid (Lenalidomide 25mg) is an anti-cancer medicine that works by enhancing the immune system to attack cancer cells while preventing growth of new blood vessels within tumors. It is used for treatment of multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. Available in 5mg, 10mg, and 25mg capsule strengths for global pharmaceutical export.
TabletImatinib 400mg
Imatinib Mesylate
First-in-class BCR-ABL tyrosine kinase inhibitor that transformed CML from a fatal disease into a chronically manageable condition, achieving complete cytogenetic response in over 80% of newly diagnosed chronic-phase patients. It also targets c-KIT and PDGFR, making it the standard first-line treatment for unresectable or metastatic GIST and Ph+ ALL. Cipla and Sun Pharma manufacture affordable Indian generics in both 100mg and 400mg tablet strengths exported to oncology programmes worldwide.
Need bulk pricing for Erlotinib 150mg?
Send us your quantity requirements and destination country for a custom quotation.
Get Bulk Quote